ST. LOUIS, March 7, 2018 /PRNewswire/ — ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported 2017 financial results with 10% annual revenue growth for the year ending December 31, 2017 and a 15%, 5-year compound annual growth rate (CAGR) in their U.S. spine market business.
“2017 was a strategic building year for us,” said Hans Stover, President and Chief Executive Officer, ulrich medical USA. “I am very proud of our performance. We experienced record organic growth in the U.S. spine market in 2017 amidst many of our competitors who reported a flat or declining spine business.”
The company also reported a 22% growth in annual case volume for 2017, and a record 131% growth in case volume for the prior 5-year period.
“We are very appreciative of our growing U.S. market acceptance and we are extremely grateful to our customers for their continued confidence in our company and our implant technologies,” said Erika Laskey, Chief Commercial Officer, ulrich medical USA.
For more information, please visit www.ulrichmedicalusa.com.
About ulrich medical USA, Inc.
ulrich medical USA is a subsidiary of ulrich medical®, an innovative medical technology company headquartered in Ulm, Germany.
Company Contact: e.laskey@ulrichmedicalusa.com
SOURCE ulrich medical USA, Inc.
Related Links
